ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	40/643	73/6033	8.75551564485955e-21	4.23766957211202e-18	3.43769193213959e-18	6356/6357/6361/6362/6347/6364/6370/10344/6348/6351/9560/1437/1440/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3586/3589/3605/29949/3552/3553/3557/51561/11009/3569/4312/4314/4318/5008/5196/6696/7124	40
WP5055	Burn wound healing	37/643	97/6033	6.79052275024604e-13	1.64330650555954e-10	1.33308683465357e-10	8038/6347/57124/1277/1278/2919/3579/2162/2200/3082/3383/3552/3553/3569/3624/3853/23643/440823/4312/4322/4313/4314/4318/64332/64127/5159/6282/6280/6423/6678/7042/7043/7076/7097/51311/3371/7124	37
WP5115	Network map of SARS-CoV-2 signaling pathway	55/643	190/6033	1.09861591988046e-12	1.77243368407381e-10	1.43783767759794e-10	59272/183/335/341/8542/684/715/838/6356/6347/6364/10344/6348/6351/1234/1051/629/3426/5199/1294/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/3091/10964/8519/10410/3458/3586/3605/8807/3552/3553/3569/3699/3726/116844/64386/114548/4939/5196/5743/6288/6289/6403/5054/6772/7124	55
WP2806	Complement system	30/643	75/6033	2.63825809765786e-11	3.192292298166e-09	2.58965860638521e-09	133/335/715/717/720/722/728/27202/958/1604/22918/629/3426/5199/2162/2214/2219/2357/2769/3383/3687/3689/5648/5329/6401/6402/6403/710/6696/7097	30
WP4891	COVID-19 adverse outcome pathway	11/643	13/6033	1.1893994258318e-09	1.15133864420518e-07	9.33991549126868e-08	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP3624	Lung fibrosis	22/643	52/6033	3.51368939813063e-09	2.83437611449204e-07	2.29930902719776e-07	6356/6347/6348/6351/1232/1051/1215/1437/1440/2920/57105/2252/26585/3082/3553/3569/4313/4318/5328/6696/7076/7124	22
WP691	Tamoxifen metabolism	12/643	17/6033	7.29269071011038e-09	5.04237471956203e-07	4.0904866689792e-07	1545/1557/1558/1559/1565/1576/2326/2328/6783/6822/54657/7364	12
WP619	Type II interferon signaling	17/643	34/6033	9.84564050647135e-09	5.95661250641517e-07	4.83213672225502e-07	4261/3627/4283/2633/3383/3433/3458/3553/3659/9636/4843/5698/8651/9021/6688/6772/6890	17
WP5088	Prostaglandin signaling	15/643	28/6033	2.2102149394778e-08	1.16636031614665e-06	9.46177463946719e-07	834/6347/6348/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	15
WP2882	Nuclear receptors meta-pathway	59/643	268/6033	2.40983536393936e-08	1.16636031614665e-06	9.46177463946719e-07	5243/1244/64240/64241/51129/335/345/8553/330/874/6347/6364/1545/1555/1557/1559/1576/1551/1907/9982/2938/2939/1839/3082/3458/3589/3553/3726/23764/4199/8431/9971/9970/5142/5743/6286/6319/5272/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/8140/5552/27286/2040/6822/7042/7056/7124/54657/7364	59
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	23/643	63/6033	4.45353980717456e-08	1.95955751515681e-06	1.58963669672355e-06	59272/6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3586/3569/3902/5196/6772/7124	23
WP2865	IL1 and megakaryocytes in obesity	13/643	23/6033	8.46762955792393e-08	3.41527725502932e-06	2.7705489693909e-06	6347/1232/2205/1839/3383/3458/3553/4318/114548/7941/6280/7076/7097	13
WP455	GPCRs, class A rhodopsin-like	33/643	118/6033	1.06630670103161e-07	3.96994187153309e-06	3.22050525898617e-06	51554/134/27202/1230/2826/1232/1234/1237/10803/3577/3579/57105/1909/2151/2867/2357/2358/29909/2828/8111/8843/3274/3352/4543/64106/4888/53829/5031/5724/5737/5739/6752/56670	33
WP2328	Allograft rejection	25/643	76/6033	1.25146343583388e-07	4.32648787816855e-06	3.50974332004538e-06	5243/717/720/721/958/1604/941/1493/6373/4283/50943/10578/3002/3119/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124	25
WP5198	Inflammatory bowel disease signaling	16/643	35/6033	1.34441885659778e-07	4.33799151062218e-06	3.51907532288402e-06	50943/3458/3586/3594/3595/8807/3552/50615/51561/3569/4094/64127/6772/30009/7097/7124	16
WP129	Matrix metalloproteinases	13/643	24/6033	1.66872778933916e-07	5.04790156275096e-06	4.09497016725992e-06	4312/4319/4321/4322/4327/4313/10893/64386/4314/4316/4318/7076/7124	13
WP1533	Vitamin B12 metabolism	16/643	37/6033	3.47231429219995e-07	9.86323331531161e-06	8.0012745250353e-06	335/338/875/6347/8029/3383/3458/3553/3569/3949/6288/6289/5054/6648/6947/7124	16
WP3617	Photodynamic therapy-induced NF-kB survival signaling	15/643	33/6033	3.66814462139688e-07	9.86323331531161e-06	8.0012745250353e-06	597/330/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/5743/6401/7124	15
WP530	Cytokines and inflammatory response	11/643	19/6033	6.2928216758841e-07	1.52737235737962e-05	1.23903847173249e-05	1437/1440/2919/2920/3458/3586/3589/3552/3553/3569/7124	11
WP4754	IL-18 signaling pathway	51/643	239/6033	6.31145602222985e-07	1.52737235737962e-05	1.23903847173249e-05	321/467/330/6362/6347/6364/6348/6351/1051/9076/24146/6900/1277/1278/1281/2920/2921/338442/3383/3458/3586/8807/3553/3559/3569/3659/3801/4312/4322/4313/4314/4318/4688/64332/4843/8431/7941/5743/6004/8698/9021/6696/30009/7052/7076/7124/7127/4982/79931/7185/80149	51
WP15	Selenium micronutrient network	20/643	59/6033	1.34486990799947e-06	3.09960493081783e-05	2.5144685497935e-05	240/335/338/875/6347/1734/3383/3458/3553/3569/8564/8942/3949/5743/6288/6289/5054/6648/7124/7498	20
WP2877	Vitamin D receptor pathway	35/643	143/6033	1.4818934786504e-06	3.26016565303088e-05	2.6447189834287e-05	5243/240/248/768/838/875/958/634/1493/1594/1555/1559/1565/1576/168002/1673/50486/3091/3488/3726/5653/639/6273/6279/6280/10568/6696/6699/79689/412/6822/7042/7056/4982/54210	35
WP4462	Platelet-mediated interactions with vascular and circulating cells	10/643	17/6033	1.71312365394149e-06	3.60500803698993e-05	2.92446280512667e-05	6347/958/3383/3553/5196/6401/6403/7042/7043/7097	10
WP24	Peptide GPCRs	16/643	41/6033	1.84438962732814e-06	3.71951908177842e-05	3.01735671488332e-05	728/1230/2826/1232/1234/1237/10803/3577/3579/10663/1909/2357/2358/4888/6752/7253	16
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/643	24/6033	1.25759624907124e-05	0.000236635156460502	0.000191963708916414	6348/6351/1230/1232/1234/1437/3458/3594/3595/7042/7043	11
WP702	Metapathway biotransformation Phase I and II	30/643	125/6033	1.27118059255641e-05	0.000236635156460502	0.000191963708916414	50515/9435/9469/1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420/2326/2327/2328/92292/2938/2939/9027/4837/6783/6822/54657/79799/7364	30
WP43	Oxidation by cytochrome P450	14/643	38/6033	1.7895555631877e-05	0.000320794404660314	0.000260235565329049	1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420	14
WP5218	Extrafollicular B cell activation by SARS-CoV-2	19/643	65/6033	2.80011605091368e-05	0.000484020060229365	0.000392647852252181	720/958/941/83416/29851/3433/8519/3458/3586/3569/9636/3687/3689/4094/639/6402/57823/30009/7124	19
WP5090	Complement system in neuronal development and plasticity	23/643	93/6033	7.91929671129448e-05	0.00132170331319535	0.00107219516272698	715/717/720/721/722/725/728/27202/843/1604/629/3426/5199/10584/2219/8547/3458/3687/3689/5648/710/7042/7043	23
WP2876	Pregnane X receptor pathway	11/643	29/6033	0.00010568359577054	0.00170502867843138	0.00138315723587409	5243/1244/1555/1557/1559/1576/1551/2939/27286/6822/54657	11
WP430	Statin inhibition of cholesterol production	10/643	25/6033	0.000129863062377804	0.00196417881846429	0.00159338560088556	64240/64241/335/337/338/341/345/3949/4547/6713	10
WP5092	Interactions of natural killer cells in pancreatic cancer	10/643	25/6033	0.000129863062377804	0.00196417881846429	0.00159338560088556	6347/6348/6351/1437/2214/3002/3458/4277/5551/7124	10
WP2289	Drug induction of bile acid pathway	7/643	13/6033	0.000145898888856235	0.00213985036989145	0.00173589427570576	5243/1244/1576/9971/9970/200931/6822	7
WP2431	Spinal cord injury	23/643	98/6033	0.000185987282784795	0.00258556946051318	0.00209747152842848	301/63827/6347/50515/1282/2919/3627/2920/2212/3383/3458/3552/3553/3569/10288/11025/4321/4318/4843/5320/5743/6403/7124	23
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	18/643	68/6033	0.000186972998177606	0.00258556946051318	0.00209747152842848	6347/958/1594/1673/10964/3458/3569/9636/5600/6300/64127/4939/91543/6258/6772/7097/51311/7124	18
WP1604	Codeine and morphine metabolism	6/643	10/6033	0.000206418100811036	0.00277517668868171	0.00225128513457651	5243/1244/1558/1565/1576/7364	6
WP2911	miRNA targets in ECM and membrane receptors	9/643	22/6033	0.000232065411018317	0.00303566645764501	0.00246260023641059	1278/1281/1282/1284/1290/50509/1291/1293/7058	9
WP545	Complement activation	8/643	18/6033	0.000263475809850281	0.00332661622028012	0.00269862516347213	715/717/720/721/1604/629/5199/5648	8
WP2875	Constitutive androstane receptor pathway	10/643	27/6033	0.000274926960353729	0.00332661622028012	0.00269862516347213	5243/1244/1555/1557/1559/1576/2939/9970/6822/54657	10
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10/643	27/6033	0.000274926960353729	0.00332661622028012	0.00269862516347213	59272/6347/2939/3553/3569/4312/4314/5593/23657/7124	10
WP117	GPCRs, other	12/643	37/6033	0.000290352842101583	0.003427579892126	0.00278052914259025	27202/1234/3577/3579/1909/29933/11245/53831/59340/53829/5737/6752	12
WP176	Folate metabolism	14/643	48/6033	0.000324086283008117	0.00360763177117754	0.00292659123673167	335/338/875/6347/3383/3458/3553/3569/3949/6288/6289/5054/6648/7124	14
WP558	Complement and coagulation cascades	14/643	48/6033	0.000324086283008117	0.00360763177117754	0.00292659123673167	715/717/721/728/1604/629/3426/5648/5328/5329/5054/710/7056/7450	14
WP2880	Glucocorticoid receptor pathway	17/643	65/6033	0.000327966524652504	0.00360763177117754	0.00292659123673167	51129/8553/330/6347/6364/1907/9982/3589/8972/9970/5142/5743/6286/5272/5552/2040/7056	17
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/643	28/6033	0.000387392534167115	0.00416662192304186	0.00338005649694348	6347/29126/941/1493/3627/3559/8651/7042/7043/51311	10
WP5174	Ulcerative colitis signaling	7/643	15/6033	0.00045165971308574	0.00475224567681518	0.0038551275281689	50943/3458/3586/4094/64127/7097/7124	7
WP4329	miRNAs involvement in the immune response in sepsis	12/643	39/6033	0.000501770699943502	0.00505952122443031	0.00410439629559048	6348/6351/3002/3383/3586/3552/3569/3659/3934/407008/51311/7124	12
WP5097	CCL18 signaling pathway	12/643	39/6033	0.000501770699943502	0.00505952122443031	0.00410439629559048	467/1237/1278/1437/3091/440823/4313/4318/6615/6772/7291/652995	12
WP2848	Pluripotent stem cell differentiation pathway	11/643	34/6033	0.00053100910352443	0.00524506951236376	0.00425491719902497	3577/22943/2255/3082/3589/3569/3624/6469/7043/7472/7474	11
WP5094	Orexin receptor pathway	24/643	112/6033	0.000580107149577745	0.00561543720791257	0.00455536772194735	8553/2920/1734/1846/1959/1960/1839/3091/3383/3586/3553/3569/3726/3949/23764/4322/4314/64106/8013/5069/6401/6696/3371/7124	24
WP167	Eicosanoid synthesis	8/643	20/6033	0.000624729700145159	0.0059288073503972	0.00480958056045706	246/240/1800/5320/80339/5730/9536/5743	8
WP4969	RAS and bradykinin pathways in COVID-19	9/643	25/6033	0.000710324056149462	0.00661147775339115	0.00536337799481274	1636/59272/183/1576/3552/3553/5054/710/7124	9
WP299	Nuclear receptors in lipid metabolism and toxicity	9/643	26/6033	0.000985198502228808	0.00883029768664339	0.00716333413901258	5243/1244/64240/1594/1555/1559/1576/9971/9970	9
WP453	Inflammatory response pathway	9/643	26/6033	0.000985198502228808	0.00883029768664339	0.00716333413901258	958/941/1277/1278/1281/3458/3559/3568/3918	9
WP75	Toll-like receptor signaling pathway	19/643	84/6033	0.00107113264674034	0.00942596729131497	0.00764655458821332	6348/6351/958/941/3627/6373/4283/3553/3569/23643/1326/5600/6300/8503/6696/6772/7097/51311/7124	19
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	11/643	37/6033	0.00117815821289315	0.0101826531257194	0.00826039498889371	84674/834/838/50506/3553/4210/91662/114548/199713/64127/639	11
WP4724	Omega-9 fatty acid synthesis	6/643	13/6033	0.00127241405536557	0.0108043579438059	0.00876473578303521	2180/2182/54898/3992/9415/6319	6
WP465	Tryptophan metabolism	10/643	33/6033	0.00166910572156414	0.0137614429204748	0.0111635889720251	8854/316/1545/1562/1576/9420/3620/8942/4129/6999	10
WP5033	Genes associated with the development of rheumatoid arthritis	7/643	18/6033	0.00167753126509921	0.0137614429204748	0.0111635889720251	958/4261/1493/3559/23569/6583/7185	7
WP697	Estrogen metabolism	6/643	14/6033	0.00202789966267285	0.0163583906122276	0.0132702907750346	1545/1576/2938/412/6783/7364	6
WP716	Vitamin A and carotenoid metabolism	10/643	34/6033	0.00214331264574736	0.0170059560744544	0.0137956102996336	64240/64241/8854/1381/1382/56603/9227/29881/5948/6258	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	6/643	15/6033	0.00307872629573091	0.0240339278569961	0.0194968575264453	335/338/3949/9388/4547/255738	6
WP5044	Kynurenine pathway and links to cell senescence	7/643	20/6033	0.00337926743731656	0.0259613561850986	0.0210604303110957	3620/169355/3458/8564/8942/6999/7124	7
WP3942	PPAR signaling pathway	13/643	54/6033	0.003599389554702	0.0272203835074339	0.022081781314208	2180/2182/51129/335/345/126129/2172/9415/4199/4312/4973/6258/6319	13
WP4478	LTF danger signal response pathway	6/643	16/6033	0.00448812263483498	0.0324216620188079	0.0263011742779803	3552/3553/3569/7097/7124/54210	6
WP4493	Cells and molecules involved in local acute inflammatory response 	6/643	16/6033	0.00448812263483498	0.0324216620188079	0.0263011742779803	3383/3552/3569/3689/6403/7124	6
WP516	Hypertrophy model	6/643	16/6033	0.00448812263483498	0.0324216620188079	0.0263011742779803	467/11072/1839/3458/3552/8013	6
WP4538	Regulatory circuits of the STAT3 signaling pathway	16/643	75/6033	0.00481930155547381	0.0343020875419018	0.0278266173404293	1271/1439/1441/2151/3595/3601/50615/3559/3568/3575/5600/6300/9180/5159/11122/9021	16
WP2884	NRF2 pathway	22/643	116/6033	0.0049000749364283	0.0343715401337869	0.0278829588297141	1244/874/2938/2939/1839/3082/23764/4199/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/7042/54657/7364	22
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/643	22/6033	0.00615268928935302	0.0425414516578123	0.0345105730064463	2919/2920/3553/5354/6469/55553/7124	7
WP3967	miR-509-3p alteration of YAP1/ECM axis	6/643	17/6033	0.00632112363004666	0.0430904765766561	0.0349559542477006	1277/1281/1909/6678/7058/7291	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/643	134/6033	0.00713398950767894	0.0479562628016196	0.0389031883971381	9076/24146/51208/1282/1284/94234/11211/3091/3678/5600/6300/4313/4318/4854/4855/8503/6615/6678/7042/7043/7291/7480/7472/7474	24
WP3893	Development and heterogeneity of the ILC family	7/643	23/6033	0.00804839241498088	0.0533619442308322	0.043288397560027	3458/3605/3553/51561/3569/30009/7124	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	5/643	13/6033	0.0084009773092681	0.0549469326714292	0.0445741754816074	2180/2182/54898/3992/9415	5
WP497	Urea cycle and metabolism of amino groups	6/643	18/6033	0.00864291981252043	0.0550417524902617	0.0446510954303341	384/445/1373/2628/4942/5009	6
WP5149	Lipid metabolism in senescent cells	6/643	18/6033	0.00864291981252043	0.0550417524902617	0.0446510954303341	240/84647/50487/283748/7941/5743	6
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	9/643	35/6033	0.00929152097786108	0.0584038461465553	0.0473785006800025	285/597/664/3091/4843/5743/5054/6515/7043	9
WP3929	Chemokine signaling pathway	26/643	152/6033	0.00960349640675782	0.0595909264214203	0.0483414866359064	6356/6361/6364/6370/10344/6348/6351/1230/2826/1232/1237/10803/3627/6373/2921/6374/4283/3579/10663/2268/2786/3055/4067/5196/8503/6772	26
WP4210	Tryptophan catabolism leading to NAD+ production	5/643	14/6033	0.011941576001821	0.0722465348110171	0.0586079980089373	3620/8564/8942/10135/6999	5
WP5063	FOXP3 in COVID-19	5/643	14/6033	0.011941576001821	0.0722465348110171	0.0586079980089373	941/50943/3559/3569/3575	5
WP4496	Signal transduction through IL1R	8/643	31/6033	0.0136079358197287	0.0813116165030705	0.065961794161908	3552/3553/3557/3569/11213/7042/7043/7124	8
WP2374	Oncostatin M signaling pathway	13/643	64/6033	0.0158131476634881	0.0925768158720846	0.0751003747722653	6347/1051/3091/3726/3949/4312/4322/4314/5008/9180/5054/9021/6772	13
WP4389	Bile acids synthesis and enterohepatic circulation 	4/643	10/6033	0.0158757762755848	0.0925768158720846	0.0751003747722653	64240/64241/3949/6555	4
WP5109	Familial hyperlipidemia type 2	5/643	15/6033	0.0163730008548661	0.0943396715923235	0.0765304425922938	335/337/338/3949/255738	5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	10/643	45/6033	0.0178413652016506	0.10159083244234	0.0824127457611846	2180/2182/9023/54898/3992/9415/4597/6319/8435/6713	10
WP727	Monoamine transport	6/643	21/6033	0.0191626182040373	0.107845432683186	0.087486616769962	183/3553/6532/6999/7124/4982	6
WP5122	Prostaglandin and leukotriene metabolism in senescence 	7/643	27/6033	0.020031714408618	0.111440801997369	0.0904032604284876	246/240/3488/5600/5730/9536/5743	7
WP4747	Netrin-UNC5B signaling pathway	10/643	46/6033	0.0206960742940345	0.11382840861719	0.0923401400918048	249/6347/1003/1277/3383/3586/3552/54538/6401/7124	10
WP247	Small ligand GPCRs	5/643	16/6033	0.0217752182276075	0.11841804069845	0.0960633518497646	4543/5724/5737/5739/8698	5
WP4136	Fibrin complement receptor 3 signaling pathway	8/643	35/6033	0.027794751513356	0.148247315037163	0.120261523507746	6347/3627/2921/3569/3689/23643/4843/7124	8
WP3287	Overview of nanoparticle effects	5/643	17/6033	0.0282144243099245	0.148247315037163	0.120261523507746	1001/1282/3569/5743/7124	5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5/643	17/6033	0.0282144243099245	0.148247315037163	0.120261523507746	249/1594/5251/142680/6696	5
WP5130	Th17 cell differentiation pathway	12/643	62/6033	0.0284855378067276	0.148247315037163	0.120261523507746	50943/3091/3458/3605/3553/50615/51561/3559/3569/9021/6772/30009	12
WP4197	Immune response to tuberculosis	6/643	23/6033	0.0296859118289485	0.152765664525355	0.123926909238706	3437/8519/3659/8651/6772/6890	6
WP364	IL6 signaling pathway	9/643	42/6033	0.029984996136175	0.152765664525355	0.123926909238706	183/3055/3569/3659/3726/639/9021/6772/7076	9
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10/643	49/6033	0.031243956551107	0.157142855478455	0.127477784022322	602/2252/1839/3458/3569/3726/5600/6300/4313/7124	10
WP4495	IL-10 anti-inflammatory signaling pathway 	4/643	12/6033	0.0314935061599383	0.157142855478455	0.127477784022322	3586/3552/3569/6772	4
WP2873	Aryl hydrocarbon receptor pathway	8/643	36/6033	0.0325216997990635	0.160617374517824	0.130296391246517	1545/2939/3458/3553/3726/8140/7124/54657	8
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	38/643	265/6033	0.0335206357428535	0.163878663631728	0.132942021606426	285/1277/1278/1281/1282/1284/1290/50509/84699/9586/1440/1441/2255/2252/2254/2786/3082/3091/3559/3575/3678/3687/3689/3918/10319/23566/4843/5008/9180/5159/5209/5228/6514/6515/6696/7058/3371/7450	38
WP236	Adipogenesis	19/643	115/6033	0.0340191830892646	0.164652846152041	0.133570055708376	183/1051/1271/56603/1959/3091/3569/10135/5008/80339/6258/6319/5054/8651/9021/6772/7124/7291/7480	19
WP474	Endochondral ossification	11/643	57/6033	0.0357958598994765	0.166560370245464	0.135117481734576	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4808	Endochondral ossification with skeletal dysplasias	11/643	57/6033	0.0357958598994765	0.166560370245464	0.135117481734576	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	6/643	24/6033	0.0361339646193672	0.166560370245464	0.135117481734576	246/240/8529/57105/1800/2358	6
WP5036	Angiotensin II receptor type 1 pathway	6/643	24/6033	0.0361339646193672	0.166560370245464	0.135117481734576	59272/183/1277/1278/3091/3589	6
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	6/643	24/6033	0.0361339646193672	0.166560370245464	0.135117481734576	1636/59272/183/3569/114548/7124	6
WP4298	Acute viral myocarditis	14/643	79/6033	0.0378499637810982	0.172824362925015	0.140198972098805	834/1232/1234/1604/941/3458/3586/3569/3689/4318/64127/8651/6772/7124	14
WP5108	Familial  hyperlipidemia type 1	4/643	13/6033	0.0417568523157916	0.187132560378177	0.151806100524272	51129/335/337/3949	4
WP554	ACE inhibitor pathway	4/643	13/6033	0.0417568523157916	0.187132560378177	0.151806100524272	1636/59272/183/1215	4
WP2895	Differentiation of white and brown adipocyte	5/643	19/6033	0.0443935919038159	0.19533180437679	0.158457509857639	1051/253738/3224/27129/51316	5
WP5066	FOXA2 pathway	5/643	19/6033	0.0443935919038159	0.19533180437679	0.158457509857639	1244/338/2938/2939/4547	5
WP3937	Microglia pathogen phagocytosis pathway	8/643	39/6033	0.0498945713991209	0.217558311325897	0.176488147291343	2207/2209/3055/3689/4067/4688/8503/54210	8
WP2849	Hematopoietic stem cell differentiation	9/643	46/6033	0.0506674774020871	0.218955884487591	0.177621889764835	4261/1437/1440/3552/3553/3569/4778/6688/23650	9
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	6/643	26/6033	0.0515522811746248	0.220808000783349	0.179124367751607	8529/5730/9536/5737/5739/5743	6
WP12	Osteoclast signaling	4/643	14/6033	0.0536829628413798	0.223987534614033	0.181703676405033	1513/8111/6696/4982	4
WP2879	Farnesoid X receptor pathway	4/643	14/6033	0.0536829628413798	0.223987534614033	0.181703676405033	1576/8431/9971/6822	4
WP3971	OSX and miRNAs in tooth development	4/643	14/6033	0.0536829628413798	0.223987534614033	0.181703676405033	249/22943/4854/4855	4
WP98	Prostaglandin synthesis and regulation	8/643	41/6033	0.0642909985392961	0.265955925581361	0.215749369816981	301/1909/3290/5730/9536/5737/5739/5743	8
WP5087	Malignant pleural mesothelioma	50/643	381/6033	0.0665008917763353	0.271242561040452	0.220038006237688	72/285/467/834/6347/6351/29126/1001/1003/1282/1284/1437/1440/115908/1496/2919/3627/6374/22943/2255/2252/2254/8061/11211/1839/3082/3091/3620/3586/3553/3569/3689/3918/10319/4313/4314/4318/114548/5159/5228/5328/6401/6423/6425/8140/6678/6772/7480/7472/7474	50
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/643	15/6033	0.0672502217455667	0.271242561040452	0.220038006237688	1051/2939/4094/23657	4
WP4842	Mammalian disorder of sexual development	4/643	15/6033	0.0672502217455667	0.271242561040452	0.220038006237688	84733/2254/5600/5730	4
WP5222	2q13 copy number variation syndrome	9/643	49/6033	0.0711898582527703	0.284759433011081	0.231003193808467	1437/3552/3553/3557/51561/3569/8651/9021/6772	9
WP4595	Urea cycle and associated pathways	5/643	22/6033	0.0772223947829821	0.306357697335765	0.248524186833929	445/1373/4843/4942/5009	5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	11/643	65/6033	0.0804318950323894	0.316496237363223	0.25674879629509	22943/1959/94234/2619/3458/3488/5653/5650/4488/22822/7474	11
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3/643	10/6033	0.0818116455774712	0.31655350179168	0.256795250474765	1116/4318/9021	3
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	7/643	36/6033	0.0819931963012703	0.31655350179168	0.256795250474765	684/8519/10581/10410/3726/5600/6300	7
WP3413	NOTCH1 regulation of endothelial cell calcification	4/643	16/6033	0.0824085562515532	0.31655350179168	0.256795250474765	249/2702/4256/55553	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	19/643	128/6033	0.0841081546297613	0.320538164100822	0.260027697280572	116/8553/720/721/1051/2328/3091/3586/3552/3553/3557/3569/3764/5354/6507/6532/6752/7124/11076	19
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/643	23/6033	0.0904269733813248	0.341926993098134	0.277378791704228	285/2022/2200/4053/5054	5
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	9/643	52/6033	0.0962206787718838	0.361014019578231	0.292862612663506	1003/1277/1278/3082/4313/4318/6615/7042/7043	9
WP5111	Familial hyperlipidemia type 4	4/643	17/6033	0.0990836737720543	0.368896139274417	0.299256763700212	335/337/3949/4547	4
WP5083	Neuroinflammation and glutamatergic signaling	17/643	115/6033	0.101234395307859	0.374026315488577	0.303418476896997	2893/2898/2906/116443/3458/3586/3552/3553/3569/29968/6507/6515/9021/6772/7042/7043/7124	17
WP3871	Valproic acid pathway	3/643	11/6033	0.103910233352587	0.375317559273522	0.304465962612056	116285/1555/1559	3
WP4583	Biomarkers for urea cycle disorders	3/643	11/6033	0.103910233352587	0.375317559273522	0.304465962612056	445/2628/5009	3
WP4707	Aspirin and miRNAs	3/643	11/6033	0.103910233352587	0.375317559273522	0.304465962612056	283120/4597/5743	3
WP3927	BMP signaling in eyelid development	4/643	18/6033	0.1171813159813	0.42011671803666	0.340808037902728	2255/2296/3625/6469	4
WP4545	Oxysterols derived from cholesterol	6/643	32/6033	0.118540159916908	0.421863510292524	0.342225074682713	134526/9023/1576/9420/3605/3638	6
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/643	12/6033	0.128049142416803	0.442684178069518	0.359115264071183	55509/1437/6688	3
WP5110	Familial hyperlipidemia type 3	3/643	12/6033	0.128049142416803	0.442684178069518	0.359115264071183	335/337/3949	3
WP5112	Familial hyperlipidemia type 5	3/643	12/6033	0.128049142416803	0.442684178069518	0.359115264071183	335/337/3949	3
WP5188	Retinol metabolism	3/643	12/6033	0.128049142416803	0.442684178069518	0.359115264071183	316/1551/9227	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	6/643	33/6033	0.132605799998397	0.453342851604905	0.367761817417637	1636/183/1215/84699/9586/3283	6
WP3646	Hepatitis C and hepatocellular carcinoma	8/643	48/6033	0.133005547371687	0.453342851604905	0.367761817417637	330/1284/3577/3091/3569/4312/4843/5743	8
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	5/643	26/6033	0.136345852407676	0.459098790665854	0.372431163371821	2254/5600/6300/6615/6772	5
WP3599	Transcription factor regulation in adipogenesis	4/643	19/6033	0.136591375735295	0.459098790665854	0.372431163371821	1051/3569/7124/7291	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	8/643	49/6033	0.145067145248548	0.484224126208948	0.392813395119481	1051/1513/3726/4129/6696/7042/4982/7480	8
WP4008	NO/cGMP/PKG mediated neuroprotection	6/643	34/6033	0.147423198307813	0.486676258360069	0.394802619330809	2906/3458/3553/4843/5593/7124	6
WP4655	Cytosolic DNA-sensing pathway	9/643	57/6033	0.14781283053498	0.486676258360069	0.394802619330809	834/843/6351/9560/3627/3553/3569/9636/81030	9
WP3869	Cannabinoid receptor signaling	5/643	27/6033	0.153570328547265	0.493413413592049	0.400267949695159	1557/1559/1576/5600/6300	5
WP4917	Proximal tubule transport	7/643	42/6033	0.153935895384921	0.493413413592049	0.400267949695159	5243/1244/6514/142680/6519/340024/11136	7
WP1434	Osteopontin signaling	3/643	13/6033	0.153936829447106	0.493413413592049	0.400267949695159	4318/5328/6696	3
WP5178	Disorders of fructose metabolism	3/643	13/6033	0.153936829447106	0.493413413592049	0.400267949695159	229/3795/6514	3
WP4787	Osteoblast differentiation and related diseases	14/643	98/6033	0.156181809096577	0.497260240220182	0.403388581126855	2255/2252/2254/11211/5600/6300/4854/4855/5288/8503/6772/7480/7472/7474	14
WP3645	NAD+ biosynthetic pathways	4/643	20/6033	0.157191770152248	0.497260240220182	0.403388581126855	952/3620/10135/6999	4
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5/643	28/6033	0.171642449714268	0.539447699101986	0.437611987309788	9509/1277/1278/60681/4982	5
WP262	Ebstein-Barr virus LMP1 signaling	4/643	21/6033	0.178852000358702	0.544962334436988	0.442085582307518	6364/9260/7124/7185	4
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/643	21/6033	0.178852000358702	0.544962334436988	0.442085582307518	941/3101/3586/6515	4
WP4564	Neural crest cell migration during development	6/643	36/6033	0.179142168003956	0.544962334436988	0.442085582307518	2047/2151/4313/4318/8503/7291	6
WP3935	Leptin-insulin signaling overlap	3/643	14/6033	0.181278793066849	0.544962334436988	0.442085582307518	8503/8651/9021	3
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3/643	14/6033	0.181278793066849	0.544962334436988	0.442085582307518	3589/3569/652995	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/643	14/6033	0.181278793066849	0.544962334436988	0.442085582307518	941/1493/8503	3
WP5061	Fatty acid transporters	3/643	14/6033	0.181278793066849	0.544962334436988	0.442085582307518	2180/2182/2172	3
WP4331	Neovascularisation processes	6/643	37/6033	0.195947941481868	0.585095483292843	0.474642486446782	3091/4318/4854/4855/7042/7043	6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	7/643	45/6033	0.198082292609452	0.585095483292843	0.474642486446782	6356/3055/3559/3569/3575/4067/6772	7
WP5053	Development of ureteric collection system	8/643	53/6033	0.198255494338897	0.585095483292843	0.474642486446782	2296/80144/158326/341640/2674/80000/6469/7042	8
WP3591	Sleep regulation	4/643	22/6033	0.201436357153307	0.590879980983034	0.479334999797025	100/134/3569/5730	4
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/643	78/6033	0.204632863391635	0.596640396876816	0.484007977457704	467/22943/8061/11211/283120/5328/6423/6425/7480/7472/7474	11
WP272	Blood clotting cascade	3/643	15/6033	0.20978593589717	0.604383291513276	0.490289186025342	5328/5054/7450	3
WP698	Glucuronidation	3/643	15/6033	0.20978593589717	0.604383291513276	0.490289186025342	54657/79799/7364	3
WP4816	TGF-beta receptor signaling in skeletal dysplasias	8/643	54/6033	0.212663318943639	0.609047611649238	0.49407298639662	2022/2200/3458/3624/5054/6696/6772/7124	8
WP4357	NRF2-ARE regulation	4/643	23/6033	0.224806753736882	0.636295139231878	0.516176787589148	1051/2939/4094/23657	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/643	23/6033	0.224806753736882	0.636295139231878	0.516176787589148	10538/29126/3458/80380	4
WP4241	Type 2 papillary renal cell carcinoma	5/643	31/6033	0.230168954268566	0.643077419897463	0.521678724710208	1513/112399/3091/7042/7043	5
WP4565	Neural crest cell migration in cancer	6/643	39/6033	0.231188989797848	0.643077419897463	0.521678724710208	2047/2151/4313/4318/8503/7291	6
WP534	Glycolysis and gluconeogenesis	6/643	39/6033	0.231188989797848	0.643077419897463	0.521678724710208	229/3099/3101/5313/6514/6515	6
WP3644	NAD+ metabolism	3/643	16/6033	0.23918071581539	0.657746968492321	0.533578989229308	952/10135/203447	3
WP4225	Pyrimidine metabolism and related diseases	3/643	16/6033	0.23918071581539	0.657746968492321	0.533578989229308	1373/5009/1890	3
WP3941	Oxidative damage response	6/643	40/6033	0.249512393934594	0.682061917751278	0.553303817575526	715/717/721/728/7124/7185	6
WP3298	Melatonin metabolism and effects	5/643	32/6033	0.250840953222578	0.682061917751278	0.553303817575526	1545/1557/1565/406938/4543	5
WP2324	AGE/RAGE pathway	9/643	65/6033	0.252530637455394	0.682820271108439	0.553919010707803	249/3091/3625/4322/4313/4316/4318/4843/6772	9
WP4830	GDNF/RET signaling axis	3/643	17/6033	0.269201510538961	0.723852950560318	0.587205634099606	2296/2674/26585	3
WP4900	Purinergic signaling	4/643	25/6033	0.273355809055759	0.730962494933632	0.592973054828719	134/5027/53829/5031	4
WP560	TGF-beta receptor signaling	7/643	50/6033	0.280635380816807	0.746305078655683	0.605419300431862	2022/3458/3624/5054/6696/6772/7124	7
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	6/643	42/6033	0.287276206612146	0.758403804262182	0.615234056089156	330/6347/3569/4318/7124/7185	6
WP4846	SARS-CoV-2 and COVID-19 pathway	2/643	10/6033	0.28945563024131	0.758403804262182	0.615234056089156	59272/340024	2
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	8/643	59/6033	0.28988575162914	0.758403804262182	0.615234056089156	1437/1493/29851/3458/3586/3937/1326/7124	8
WP4172	PI3K-Akt signaling pathway	33/643	280/6033	0.293237777032639	0.763048839160199	0.619002211845921	285/1277/1278/1282/1284/1291/1293/84699/9586/1440/1441/2255/2252/2254/2786/3082/3559/3569/3575/3678/3918/10319/23566/5008/9180/5159/5228/8503/6696/7058/7097/3371/7450	33
WP3877	MYD88 distinct input-output pathway	3/643	18/6033	0.299605549450494	0.775449657401278	0.629062031776156	3552/7097/51311	3
WP2371	Parkinson's disease pathway	5/643	35/6033	0.315171031203118	0.811397761182496	0.65822393414761	120892/5600/6300/9627/9246	5
WP2197	Endothelin pathways	4/643	27/6033	0.323431298389238	0.816596751428249	0.66244147081935	1909/2769/4852/5739	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/643	19/6033	0.330170707022094	0.816596751428249	0.66244147081935	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/643	19/6033	0.330170707022094	0.816596751428249	0.66244147081935	2180/7124/7185	3
WP229	Irinotecan pathway	2/643	11/6033	0.330687940661026	0.816596751428249	0.66244147081935	1244/1576	2
WP3630	NAD metabolism, sirtuins and aging	2/643	11/6033	0.330687940661026	0.816596751428249	0.66244147081935	3091/10135	2
WP3930	EDA signaling in hair follicle development	2/643	11/6033	0.330687940661026	0.816596751428249	0.66244147081935	22943/6469	2
WP4271	Vitamin B12 disorders	2/643	11/6033	0.330687940661026	0.816596751428249	0.66244147081935	8029/6947	2
WP5052	Nephrogenesis	2/643	11/6033	0.330687940661026	0.816596751428249	0.66244147081935	8854/80000	2
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	7/643	53/6033	0.333725291723109	0.819913914690277	0.665132427532565	843/3627/3458/9636/5600/6300/7124	7
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/643	28/6033	0.348729439835067	0.852294658839794	0.691400408323713	3082/7042/7043/7474	4
WP2018	RANKL/RANK signaling pathway	7/643	54/6033	0.351755798307284	0.852294658839794	0.691400408323713	1513/3383/4067/6688/6772/4982/7185	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	9/643	72/6033	0.358864453263151	0.852294658839794	0.691400408323713	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP3640	Imatinib and chronic myeloid leukemia	3/643	20/6033	0.360696401763831	0.852294658839794	0.691400408323713	5243/5159/11040	3
WP4224	Purine metabolism and related disorders	3/643	20/6033	0.360696401763831	0.852294658839794	0.691400408323713	100/316/7498	3
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3/643	20/6033	0.360696401763831	0.852294658839794	0.691400408323713	3569/4318/6696	3
WP4963	p53 transcriptional gene network	10/643	81/6033	0.360992572442475	0.852294658839794	0.691400408323713	6347/126129/55332/3383/9636/4688/5268/5054/23657/7124	10
WP5098	T-cell activation SARS-CoV-2	10/643	81/6033	0.360992572442475	0.852294658839794	0.691400408323713	941/1493/29851/3458/3594/3595/3605/51561/3937/7124	10
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2/643	12/6033	0.371215700309871	0.855563804523703	0.69405241210818	8061/7076	2
WP2881	Estrogen receptor pathway	2/643	12/6033	0.371215700309871	0.855563804523703	0.69405241210818	1545/8431	2
WP4211	Transcriptional cascade regulating adipogenesis	2/643	12/6033	0.371215700309871	0.855563804523703	0.69405241210818	1051/1959	2
WP4792	Purine metabolism	2/643	12/6033	0.371215700309871	0.855563804523703	0.69405241210818	100/7498	2
WP5171	Leukotriene metabolic pathway	2/643	12/6033	0.371215700309871	0.855563804523703	0.69405241210818	240/1800	2
WP4018	Clear cell renal cell carcinoma pathways	10/643	83/6033	0.390765365847835	0.892669057391705	0.724153019589182	229/3091/3099/3101/4199/5159/5313/29968/7042/7043	10
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3/643	21/6033	0.39100380199802	0.892669057391705	0.724153019589182	5600/6300/7124	3
WP306	Focal adhesion	21/643	183/6033	0.393446723978692	0.894029175613554	0.72525637778133	330/1277/1278/1282/1284/1290/50509/2268/2318/3055/3082/3678/3918/10319/5159/5228/8503/6696/7058/3371/7450	21
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/643	30/6033	0.399282999323506	0.898851031035241	0.729167974284786	3624/6469/6615/7474	4
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	4/643	30/6033	0.399282999323506	0.898851031035241	0.729167974284786	59272/4939/6772/7097	4
WP2828	Bladder cancer	5/643	39/6033	0.403337084461877	0.899497464189597	0.729692375256024	1839/4312/4313/4318/1890	5
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/643	13/6033	0.410720949557647	0.899497464189597	0.729692375256024	4312/5743	2
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2/643	13/6033	0.410720949557647	0.899497464189597	0.729692375256024	249/7124	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/643	13/6033	0.410720949557647	0.899497464189597	0.729692375256024	1244/9420	2
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	2/643	13/6033	0.410720949557647	0.899497464189597	0.729692375256024	56624/3091	2
WP692	Sulfation biotransformation reaction	2/643	13/6033	0.410720949557647	0.899497464189597	0.729692375256024	6783/6822	2
WP357	Fatty acid biosynthesis	3/643	22/6033	0.420935503815606	0.913599927563915	0.741132607614921	2180/2182/6319	3
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3/643	22/6033	0.420935503815606	0.913599927563915	0.741132607614921	1244/5600/6300	3
WP2406	Cardiac progenitor differentiation	4/643	31/6033	0.424336931924238	0.916870870764871	0.743786069585248	290/22943/3624/7070	4
WP69	T-cell receptor signaling pathway	10/643	86/6033	0.435627790225416	0.937083779862672	0.760183231598035	1234/29851/3601/3605/3552/3553/3569/3937/1326/3604	10
WP3925	Amino acid metabolism	9/643	77/6033	0.437896911002881	0.937796924448649	0.760761750368303	384/445/586/875/1373/3034/4942/5009/6999	9
WP5220	Metabolic reprogramming in pancreatic cancer	5/643	41/6033	0.447129324908288	0.943600567543154	0.765469794896904	3099/3949/4199/9122/8140	5
WP58	Monoamine GPCRs	2/643	14/6033	0.448961308972779	0.943600567543154	0.765469794896904	3274/3352	2
WP3845	Canonical and non-canonical Notch signaling	3/643	23/6033	0.450354816327414	0.943600567543154	0.765469794896904	4237/4854/4855	3
WP4483	Relationship between inflammation, COX-2 and EGFR	3/643	23/6033	0.450354816327414	0.943600567543154	0.765469794896904	4312/51365/5743	3
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3/643	23/6033	0.450354816327414	0.943600567543154	0.765469794896904	3553/3569/10135	3
WP4666	Hepatitis B infection	15/643	134/6033	0.461235399088346	0.962232470511894	0.780584409527917	843/84699/9586/1959/1960/3569/5600/6300/4318/8503/6772/7042/7043/7097/7124	15
WP3945	TYROBP causal network in microglia	7/643	61/6033	0.478448131477065	0.975546223170736	0.791384822189397	10261/3687/3689/4094/4688/5341/6696	7
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/643	52/6033	0.483829085465847	0.975546223170736	0.791384822189397	602/79092/3575/9021/7124/7185	6
WP395	IL-4 signaling pathway	6/643	52/6033	0.483829085465847	0.975546223170736	0.791384822189397	1051/9046/5600/8651/9021/6772	6
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/643	80/6033	0.484982172714158	0.975546223170736	0.791384822189397	1734/50506/405753/4852/5593/6469/5172/7038/7253	9
WP197	Cholesterol biosynthesis pathway	2/643	15/6033	0.48575752021518	0.975546223170736	0.791384822189397	4597/6713	2
WP2855	Dopaminergic neurogenesis	2/643	15/6033	0.48575752021518	0.975546223170736	0.791384822189397	4929/6469	2
WP4159	GABA receptor signaling	2/643	15/6033	0.48575752021518	0.975546223170736	0.791384822189397	2557/2562	2
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/643	15/6033	0.48575752021518	0.975546223170736	0.791384822189397	2254/5600	2
WP5182	Pro-survival signaling of neuroprotectin D1	2/643	15/6033	0.48575752021518	0.975546223170736	0.791384822189397	330/7124	2
WP5205	Clock-controlled autophagy in bone metabolism	8/643	71/6033	0.490247449464326	0.980494898928651	0.79539929817396	8553/115908/1513/22943/3569/4982/7480/7474	8
WP1591	Heart development	4/643	34/6033	0.49757682630005	0.991058370079113	0.803968621225552	8553/2255/2296/6469	4
WP4673	Male infertility	11/643	100/6033	0.503859953593827	0.993879096234693	0.806256857102089	5243/338/56603/2346/4313/4318/4843/29968/6648/7124/10537	11
WP205	IL-7 signaling pathway	3/643	25/6033	0.507206894152829	0.993879096234693	0.806256857102089	3559/3575/6772	3
WP3613	Photodynamic therapy-induced unfolded protein response	3/643	25/6033	0.507206894152829	0.993879096234693	0.806256857102089	467/121506/6783	3
WP4950	16p11.2 distal deletion syndrome	3/643	25/6033	0.507206894152829	0.993879096234693	0.806256857102089	8519/5350/7185	3
WP2267	Synaptic vesicle pathway	5/643	44/6033	0.511079960941598	0.996662705713455	0.808514983103782	22999/246213/6507/6581/6532	5
WP2858	Ectoderm differentiation	13/643	120/6033	0.519391468021584	0.996662705713455	0.808514983103782	398/6347/1496/54898/57476/9687/152789/3801/3853/4061/6469/6781/4982	13
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2/643	16/6033	0.520982777986579	0.996662705713455	0.808514983103782	3949/6319	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/643	16/6033	0.520982777986579	0.996662705713455	0.808514983103782	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/643	16/6033	0.520982777986579	0.996662705713455	0.808514983103782	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/643	16/6033	0.520982777986579	0.996662705713455	0.808514983103782	3569/64386	2
WP3594	Circadian rhythm genes	17/643	159/6033	0.533422062965909	0.999999178804216	0.811221604380105	100/134/56938/8553/1960/50865/3569/4543/4547/10135/4843/5551/5593/60675/5730/5054/6532	17
WP3851	TLR4 signaling and tolerance	3/643	26/6033	0.534459961616524	0.999999178804216	0.811221604380105	3569/11213/7124	3
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	3/643	26/6033	0.534459961616524	0.999999178804216	0.811221604380105	2557/2562/8503	3
WP4658	Small cell lung cancer	10/643	93/6033	0.538375069345039	0.999999178804216	0.811221604380105	330/1282/1284/3918/10319/4843/8503/5743/6258/7185	10
WP254	Apoptosis	9/643	84/6033	0.546100114392499	0.999999178804216	0.811221604380105	330/834/843/3002/8739/3659/5551/7124/7185	9
WP3303	RAC1/PAK1/p38/MMP2 pathway	7/643	65/6033	0.548092279243649	0.999999178804216	0.811221604380105	285/9046/5600/6300/4313/4843/79931	7
WP100	Glutathione metabolism	2/643	17/6033	0.554553613646262	0.999999178804216	0.811221604380105	290/2938	2
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2/643	17/6033	0.554553613646262	0.999999178804216	0.811221604380105	3371/7472	2
WP3874	Canonical and non-canonical TGF-B signaling	2/643	17/6033	0.554553613646262	0.999999178804216	0.811221604380105	26585/4017	2
WP4784	Proteoglycan biosynthesis	2/643	17/6033	0.554553613646262	0.999999178804216	0.811221604380105	9469/55790	2
WP4912	SARS coronavirus and innate immunity	2/643	17/6033	0.554553613646262	0.999999178804216	0.811221604380105	59272/6772	2
WP5074	Kallmann syndrome	2/643	17/6033	0.554553613646262	0.999999178804216	0.811221604380105	60675/9723	2
WP2643	Nanoparticle-mediated activation of receptor signaling	3/643	27/6033	0.560838544519935	0.999999178804216	0.811221604380105	1277/5600/6300	3
WP286	IL-3 signaling pathway	5/643	47/6033	0.571808590203326	0.999999178804216	0.811221604380105	1232/1439/3055/3568/4067	5
WP4150	Wnt signaling in kidney disease	3/643	28/6033	0.586291637082119	0.999999178804216	0.811221604380105	7480/7472/7474	3
WP4561	Cell migration and invasion through p75NTR	3/643	28/6033	0.586291637082119	0.999999178804216	0.811221604380105	4313/4318/7291	3
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	2/643	18/6033	0.586422121670732	0.999999178804216	0.811221604380105	6615/3371	2
WP4760	PKC-gamma calcium signaling pathway in ataxia	2/643	18/6033	0.586422121670732	0.999999178804216	0.811221604380105	2769/2893	2
WP5193	Cholesterol synthesis disorders	2/643	18/6033	0.586422121670732	0.999999178804216	0.811221604380105	4597/6713	2
WP399	Wnt signaling pathway and pluripotency	9/643	87/6033	0.590030420300582	0.999999178804216	0.811221604380105	8061/11211/3949/120892/4316/5328/7480/7472/7474	9
WP127	IL-5 signaling pathway	4/643	39/6033	0.609468359896828	0.999999178804216	0.811221604380105	1439/3568/4067/6772	4
WP408	Oxidative stress response	3/643	29/6033	0.610781251920338	0.999999178804216	0.811221604380105	3726/6648/7498	3
WP4698	Vitamin D-sensitive calcium signaling in depression	3/643	29/6033	0.610781251920338	0.999999178804216	0.811221604380105	775/1594/2906	3
WP1584	Type II diabetes mellitus	2/643	19/6033	0.616569346923513	0.999999178804216	0.811221604380105	6514/7124	2
WP325	Triacylglyceride synthesis	2/643	19/6033	0.616569346923513	0.999999178804216	0.811221604380105	56895/2819	2
WP4722	Glycerolipids and glycerophospholipids	2/643	19/6033	0.616569346923513	0.999999178804216	0.811221604380105	56895/80339	2
WP4657	22q11.2 copy number variation syndrome	9/643	90/6033	0.631869424324734	0.999999178804216	0.811221604380105	8854/9076/56603/2255/2296/4942/5625/6469/7450	9
WP4149	White fat cell differentiation	3/643	30/6033	0.634281057764431	0.999999178804216	0.811221604380105	1051/1959/7480	3
WP4313	Ferroptosis	6/643	61/6033	0.644623333017028	0.999999178804216	0.811221604380105	2180/2182/246/875/1803/23657	6
WP2878	PPAR-alpha pathway	2/643	20/6033	0.644999674163478	0.999999178804216	0.811221604380105	335/345	2
WP3580	Methionine de novo and salvage pathway	2/643	20/6033	0.644999674163478	0.999999178804216	0.811221604380105	51074/259307	2
WP2332	Interleukin-11 signaling pathway	4/643	41/6033	0.64969242705913	0.999999178804216	0.811221604380105	3383/3589/9021/6772	4
WP4844	Influence of laminopathies on Wnt signaling	3/643	31/6033	0.656775071247309	0.999999178804216	0.811221604380105	1051/6696/7480	3
WP382	MAPK signaling pathway	21/643	210/6033	0.65731765275761	0.999999178804216	0.811221604380105	775/994/1846/2255/2252/2254/2318/3310/3552/3553/120892/1326/5600/6300/22808/5159/283748/115727/7042/7043/7124	21
WP2359	Parkin-ubiquitin proteasomal system pathway	6/643	62/6033	0.660528713486882	0.999999178804216	0.811221604380105	834/3310/9627/10381/84617/9246	6
WP1423	Ganglio sphingolipid metabolism	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	6482	1
WP2333	Trans-sulfuration pathway	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	875	1
WP2436	Dopamine metabolism	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	4129	1
WP3656	Interleukin-1 induced activation of NF-kB	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	3552	1
WP5050	TCA cycle in senescence	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	4199	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	629	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/643	10/6033	0.676281495752137	0.999999178804216	0.811221604380105	51311	1
WP4823	Genes controlling nephrogenesis	3/643	32/6033	0.678256416024055	0.999999178804216	0.811221604380105	2296/5159/6469	3
WP2586	Aryl hydrocarbon receptor pathway	4/643	43/6033	0.687066817535782	0.999999178804216	0.811221604380105	1545/135112/5743/7124	4
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4/643	43/6033	0.687066817535782	0.999999178804216	0.811221604380105	775/2906/116443/8503	4
WP4482	Vitamin D in inflammatory diseases	2/643	22/6033	0.696816139554265	0.999999178804216	0.811221604380105	3569/7124	2
WP410	Exercise-induced circadian regulation	4/643	44/6033	0.7046655031952	0.999999178804216	0.811221604380105	1051/50486/2674/10381	4
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/643	11/6033	0.710840851261248	0.999999178804216	0.811221604380105	952	1
WP4788	Autosomal recessive osteopetrosis pathways	1/643	11/6033	0.710840851261248	0.999999178804216	0.811221604380105	29887	1
WP4919	Neuroinflammation	1/643	11/6033	0.710840851261248	0.999999178804216	0.811221604380105	4843	1
WP4947	Nitric oxide metabolism in cystic fibrosis	1/643	11/6033	0.710840851261248	0.999999178804216	0.811221604380105	4843	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/643	11/6033	0.710840851261248	0.999999178804216	0.811221604380105	2358	1
WP170	Nuclear receptors	3/643	34/6033	0.71819222242636	0.999999178804216	0.811221604380105	9970/4929/6258	3
WP2361	Gastric cancer network 1	2/643	23/6033	0.720288646528251	0.999999178804216	0.811221604380105	11082/6286	2
WP34	Ovarian infertility	2/643	23/6033	0.720288646528251	0.999999178804216	0.811221604380105	1051/2701	2
WP5064	7-oxo-C and 7-beta-HC pathways	2/643	23/6033	0.720288646528251	0.999999178804216	0.811221604380105	134526/3290	2
WP428	Wnt signaling	9/643	98/6033	0.731154625819321	0.999999178804216	0.811221604380105	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP3527	Pre-implantation embryo	3/643	35/6033	0.736668394098319	0.999999178804216	0.811221604380105	366/55509/94234	3
WP2513	Nanoparticle triggered regulated necrosis	1/643	12/6033	0.741715864984101	0.999999178804216	0.811221604380105	7124	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/643	12/6033	0.741715864984101	0.999999178804216	0.811221604380105	22943	1
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	1/643	12/6033	0.741715864984101	0.999999178804216	0.811221604380105	4597	1
WP4504	Cysteine and methionine catabolism	1/643	12/6033	0.741715864984101	0.999999178804216	0.811221604380105	875	1
WP5173	Disorders of galactose metabolism 	1/643	12/6033	0.741715864984101	0.999999178804216	0.811221604380105	6514	1
WP1539	Angiogenesis	2/643	24/6033	0.74221081767253	0.999999178804216	0.811221604380105	3091/4318	2
WP26	S1P receptor signal transduction	2/643	24/6033	0.74221081767253	0.999999178804216	0.811221604380105	6300/8877	2
WP289	Myometrial relaxation and contraction pathways	12/643	131/6033	0.75373601301579	0.999999178804216	0.811221604380105	133/467/2786/3488/3553/3569/23764/5142/10268/6004/5999/8490	12
WP1528	Physiological and pathological hypertrophy of the heart	2/643	25/6033	0.762645941456852	0.999999178804216	0.811221604380105	183/5600	2
WP581	EPO receptor signaling	2/643	25/6033	0.762645941456852	0.999999178804216	0.811221604380105	8651/6772	2
WP3931	Embryonic stem cell pluripotency pathways	8/643	91/6033	0.768337611536478	0.999999178804216	0.811221604380105	2255/2252/2254/6300/5159/7480/7472/7474	8
WP304	Kit receptor signaling pathway	5/643	59/6033	0.768550203922396	0.999999178804216	0.811221604380105	3726/4067/6615/8651/6772	5
WP5037	Riboflavin and CoQ disorders	1/643	13/6033	0.769298774602972	0.999999178804216	0.811221604380105	55065	1
WP1422	Sphingolipid pathway	2/643	26/6033	0.781661439776879	0.999999178804216	0.811221604380105	56624/8877	2
WP241	One-carbon metabolism	2/643	26/6033	0.781661439776879	0.999999178804216	0.811221604380105	2346/2745	2
WP4875	Disruption of postsynaptic signaling by CNV	2/643	26/6033	0.781661439776879	0.999999178804216	0.811221604380105	2906/9378	2
WP2272	Pathogenic Escherichia coli infection	4/643	49/6033	0.781865060688678	0.999999178804216	0.811221604380105	9076/23643/10381/84617	4
WP710	DNA damage response (only ATM dependent)	9/643	103/6033	0.783254111542676	0.999999178804216	0.811221604380105	8061/3949/5288/8503/5328/6648/7480/7472/7474	9
WP4758	Nephrotic syndrome	3/643	38/6033	0.786364670786918	0.999999178804216	0.811221604380105	8542/1493/8029	3
WP3915	Angiopoietin-like protein 8 regulatory pathway	11/643	125/6033	0.792560775591134	0.999999178804216	0.811221604380105	64240/64241/1555/1576/1734/1326/5600/6300/5288/8503/6319	11
WP536	Calcium regulation in cardiac cells	11/643	125/6033	0.792560775591134	0.999999178804216	0.811221604380105	775/2701/2702/2709/10052/2786/3760/5350/6004/5999/8490	11
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/643	14/6033	0.793940118112987	0.999999178804216	0.811221604380105	283120	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/643	14/6033	0.793940118112987	0.999999178804216	0.811221604380105	1890	1
WP47	Hedgehog signaling pathway	1/643	14/6033	0.793940118112987	0.999999178804216	0.811221604380105	6469	1
WP2112	IL-17 signaling pathway	2/643	27/6033	0.799327271397435	0.999999178804216	0.811221604380105	1051/3605	2
WP2525	Trans-sulfuration and one-carbon metabolism	2/643	27/6033	0.799327271397435	0.999999178804216	0.811221604380105	875/29968	2
WP2533	Glycerophospholipid biosynthetic pathway	2/643	27/6033	0.799327271397435	0.999999178804216	0.811221604380105	2819/5320	2
WP5085	Vasopressin-regulated water reabsorption	3/643	39/6033	0.801106030027759	0.999999178804216	0.811221604380105	398/84699/9586	3
WP1772	Apoptosis modulation and signaling	7/643	84/6033	0.806043674190421	0.999999178804216	0.811221604380105	597/330/664/834/843/8739/8794	7
WP4630	Measles virus infection	10/643	117/6033	0.8138278912807	0.999999178804216	0.811221604380105	3310/3552/3553/3559/3569/4939/8503/6504/6772/7097	10
WP3940	One-carbon metabolism and related pathways	3/643	40/6033	0.814985153555084	0.999999178804216	0.811221604380105	64902/586/6648	3
WP4222	Phosphodiesterases in neuronal function	3/643	40/6033	0.814985153555084	0.999999178804216	0.811221604380105	2906/10846/5142	3
WP4481	Resistin as a regulator of inflammation	2/643	28/6033	0.815714627883228	0.999999178804216	0.811221604380105	3569/7124	2
WP5038	Mitochondrial immune response to SARS-CoV-2	2/643	28/6033	0.815714627883228	0.999999178804216	0.811221604380105	1636/59272	2
WP1946	Cori cycle	1/643	15/6033	0.815953160819973	0.999999178804216	0.811221604380105	6514	1
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	1/643	15/6033	0.815953160819973	0.999999178804216	0.811221604380105	201294	1
WP4962	Airway smooth muscle cell contraction	1/643	15/6033	0.815953160819973	0.999999178804216	0.811221604380105	952	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/643	15/6033	0.815953160819973	0.999999178804216	0.811221604380105	3091	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	3/643	41/6033	0.82803457933108	0.999999178804216	0.811221604380105	843/3552/7124	3
WP4290	Metabolic reprogramming in colon cancer	3/643	41/6033	0.82803457933108	0.999999178804216	0.811221604380105	229/3101/29968	3
WP49	IL-2 signaling pathway	3/643	41/6033	0.82803457933108	0.999999178804216	0.811221604380105	3559/9021/6772	3
WP3972	PDGFR-beta pathway	2/643	29/6033	0.830894877954553	0.999999178804216	0.811221604380105	5159/6772	2
WP4321	Thermogenesis	8/643	98/6033	0.834394339473205	0.999999178804216	0.811221604380105	2180/2182/126129/84699/9586/5600/6300/5593	8
WP22	IL-9 signaling pathway	1/643	16/6033	0.835617853008866	0.999999178804216	0.811221604380105	6772	1
WP4815	Glycosaminoglycan degradation	1/643	16/6033	0.835617853008866	0.999999178804216	0.811221604380105	3373	1
WP4970	Galanin receptor pathway	1/643	16/6033	0.835617853008866	0.999999178804216	0.811221604380105	3569	1
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/643	65/6033	0.83704619048858	0.999999178804216	0.811221604380105	941/9076/22943/4311/5329	5
WP195	IL-1 signaling pathway	4/643	54/6033	0.842138042097059	0.999999178804216	0.811221604380105	6347/3552/3553/11213	4
WP143	Fatty acid beta-oxidation	2/643	30/6033	0.844938722253848	0.999999178804216	0.811221604380105	2180/2182	2
WP3858	Toll-like receptor signaling related to MyD88	2/643	30/6033	0.844938722253848	0.999999178804216	0.811221604380105	7097/51311	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5/643	66/6033	0.846675205036018	0.999999178804216	0.811221604380105	3638/3949/4597/6319/6713	5
WP1971	Integrated cancer pathway	3/643	43/6033	0.8517795161294	0.999999178804216	0.811221604380105	994/4312/6772	3
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	1/643	17/6033	0.853184367969029	0.999999178804216	0.811221604380105	728689	1
WP5200	Dravet syndrome	1/643	17/6033	0.853184367969029	0.999999178804216	0.811221604380105	5600	1
WP2636	Common pathways underlying drug addiction	2/643	31/6033	0.85791552577154	0.999999178804216	0.811221604380105	72/2893	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/643	31/6033	0.85791552577154	0.999999178804216	0.811221604380105	3283/4318	2
WP2064	Neural crest differentiation	5/643	68/6033	0.864523863654656	0.999999178804216	0.811221604380105	4488/4854/4855/6615/7291	5
WP4217	Ebola virus infection in host	10/643	124/6033	0.865020691399755	0.999999178804216	0.811221604380105	432/684/93978/2318/3119/3134/3678/8503/9021/6772	10
WP3670	Interactions between LOXL4 and oxidative stress pathway	1/643	18/6033	0.868876264810105	0.999999178804216	0.811221604380105	2252	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/643	18/6033	0.868876264810105	0.999999178804216	0.811221604380105	22808	1
WP3995	Prion disease pathway	2/643	32/6033	0.869892799754706	0.999999178804216	0.811221604380105	10538/6688	2
WP4542	Leukocyte-intrinsic Hippo pathway functions	2/643	32/6033	0.869892799754706	0.999999178804216	0.811221604380105	50943/639	2
WP231	TNF-alpha signaling pathway	7/643	92/6033	0.873310115071116	0.999999178804216	0.811221604380105	330/6347/3569/1326/6401/7124/7185	7
WP4396	Nonalcoholic fatty liver disease	11/643	137/6033	0.877724377082545	0.999999178804216	0.811221604380105	6347/84701/3552/3553/3569/56901/9971/8503/5313/9021/7124	11
WP3529	Zinc homeostasis	2/643	33/6033	0.880935808896153	0.999999178804216	0.811221604380105	7780/169026	2
WP4874	CAMKK2 pathway	2/643	33/6033	0.880935808896153	0.999999178804216	0.811221604380105	3383/4094	2
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2/643	33/6033	0.880935808896153	0.999999178804216	0.811221604380105	4939/6772	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/643	19/6033	0.882893315803804	0.999999178804216	0.811221604380105	8877	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/643	19/6033	0.882893315803804	0.999999178804216	0.811221604380105	3091	1
WP5103	Progeria-associated lipodystrophy	1/643	19/6033	0.882893315803804	0.999999178804216	0.811221604380105	2200	1
WP5194	Synthesis of ceramides and 1-deoxyceramides	1/643	19/6033	0.882893315803804	0.999999178804216	0.811221604380105	8877	1
WP400	p38 MAPK signaling pathway	2/643	34/6033	0.891107283050515	0.999999178804216	0.811221604380105	6772/7042	2
WP4262	Breast cancer pathway	10/643	129/6033	0.894192870211607	0.999999178804216	0.811221604380105	2255/2252/2254/11211/4854/4855/8503/7480/7472/7474	10
WP2507	Nanomaterial induced apoptosis	1/643	20/6033	0.895414033784874	0.999999178804216	0.811221604380105	5551	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/643	20/6033	0.895414033784874	0.999999178804216	0.811221604380105	3002	1
WP4725	Sphingolipid metabolism overview	1/643	20/6033	0.895414033784874	0.999999178804216	0.811221604380105	8877	1
WP4288	MTHFR deficiency	1/643	21/6033	0.906597931386126	0.999999178804216	0.811221604380105	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/643	21/6033	0.906597931386126	0.999999178804216	0.811221604380105	8877	1
WP4905	1q21.1 copy number variation syndrome	1/643	21/6033	0.906597931386126	0.999999178804216	0.811221604380105	2702	1
WP2637	Interleukin-1 (IL-1) structural pathway	3/643	49/6033	0.906658636547828	0.999999178804216	0.811221604380105	3552/1326/5600	3
WP4932	7q11.23 copy number variation syndrome	6/643	86/6033	0.908409602154266	0.999999178804216	0.811221604380105	9076/2200/3224/5313/9246/7472	6
WP2447	Amyotrophic lateral sclerosis (ALS)	2/643	36/6033	0.909072734096851	0.999999178804216	0.811221604380105	834/7124	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/643	36/6033	0.909072734096851	0.999999178804216	0.811221604380105	3488/8744	2
WP623	Oxidative phosphorylation	2/643	36/6033	0.909072734096851	0.999999178804216	0.811221604380105	3002/56901	2
WP2037	Prolactin signaling pathway	5/643	75/6033	0.913809046283161	0.999999178804216	0.811221604380105	3659/4843/8651/9021/6772	5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	1/643	22/6033	0.916587540520976	0.999999178804216	0.811221604380105	597	1
WP4537	Hippo-Yap signaling pathway	1/643	22/6033	0.916587540520976	0.999999178804216	0.811221604380105	3627	1
WP4686	Leucine, isoleucine and valine metabolism	1/643	22/6033	0.916587540520976	0.999999178804216	0.811221604380105	586	1
WP4148	Splicing factor NOVA regulated synaptic proteins	2/643	37/6033	0.916978027850646	0.999999178804216	0.811221604380105	1600/2898	2
WP4249	Hedgehog signaling pathway	2/643	37/6033	0.916978027850646	0.999999178804216	0.811221604380105	2619/6469	2
WP500	Glycogen synthesis and degradation	2/643	38/6033	0.924234325465297	0.999999178804216	0.811221604380105	3099/3101	2
WP4541	Hippo-Merlin signaling dysregulation	7/643	101/6033	0.924687299112162	0.999999178804216	0.811221604380105	1001/1003/3627/3678/3687/3689/5159	7
WP3658	Wnt/beta-catenin signaling pathway in leukemia	1/643	23/6033	0.925510217520646	0.999999178804216	0.811221604380105	22943	1
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/643	23/6033	0.925510217520646	0.999999178804216	0.811221604380105	5054	1
WP4906	3q29 copy number variation syndrome	3/643	52/6033	0.926540217050687	0.999999178804216	0.811221604380105	3091/8503/200931	3
WP2355	Corticotropin-releasing hormone signaling pathway	5/643	78/6033	0.929585887550999	0.999999178804216	0.811221604380105	8061/3283/3726/4929/6822	5
WP5124	Alzheimer's disease	18/643	226/6033	0.930876018389788	0.999999178804216	0.811221604380105	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP2526	PDGF pathway	2/643	39/6033	0.930889909002461	0.999999178804216	0.811221604380105	5159/6772	2
WP585	Interferon type I signaling pathways	3/643	53/6033	0.932252360624959	0.999999178804216	0.811221604380105	8651/9021/6772	3
WP4521	Glycosylation and related congenital defects	1/643	24/6033	0.933479756644477	0.999999178804216	0.811221604380105	79644	1
WP4925	Unfolded protein response	1/643	24/6033	0.933479756644477	0.999999178804216	0.811221604380105	3553	1
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	1/643	24/6033	0.933479756644477	0.999999178804216	0.811221604380105	2769	1
WP4312	Rett syndrome causing genes	2/643	40/6033	0.936990159289166	0.999999178804216	0.811221604380105	3766/23221	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5/643	80/6033	0.938622530870815	0.999999178804216	0.811221604380105	183/8503/5320/7124/7474	5
WP2059	Alzheimer's disease and miRNA effects	18/643	229/6033	0.9392438092169	0.999999178804216	0.811221604380105	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP268	Notch signaling	2/643	41/6033	0.942577624928042	0.999999178804216	0.811221604380105	4854/4855	2
WP4806	EGFR tyrosine kinase inhibitor resistance	5/643	82/6033	0.946604453314293	0.999999178804216	0.811221604380105	3082/3569/22808/5159/8503	5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/643	26/6033	0.946955287977311	0.999999178804216	0.811221604380105	1051	1
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2/643	42/6033	0.947692109549114	0.999999178804216	0.811221604380105	72/3689	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/643	42/6033	0.947692109549114	0.999999178804216	0.811221604380105	7042/7043	2
WP61	Notch signaling pathway	3/643	57/6033	0.951241347043989	0.999999178804216	0.811221604380105	3091/4854/4855	3
WP3996	Ethanol effects on histone modifications	1/643	27/6033	0.952633288614999	0.999999178804216	0.811221604380105	8854	1
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1/643	27/6033	0.952633288614999	0.999999178804216	0.811221604380105	1959	1
WP5102	Familial partial lipodystrophy (FPLD)	1/643	27/6033	0.952633288614999	0.999999178804216	0.811221604380105	5396	1
WP5121	Sphingolipid metabolism in senescence	1/643	27/6033	0.952633288614999	0.999999178804216	0.811221604380105	8877	1
WP4255	Non-small cell lung cancer	4/643	71/6033	0.953399988108698	0.999999178804216	0.811221604380105	1381/1382/8503/6258	4
WP1403	AMP-activated protein kinase (AMPK) signaling	3/643	58/6033	0.955144375845818	0.999999178804216	0.811221604380105	126129/5209/8503	3
WP2038	Microtubule cytoskeleton regulation	2/643	44/6033	0.956648240097167	0.999999178804216	0.811221604380105	2151/11076	2
WP2583	T cell receptor and co-stimulatory signaling	1/643	28/6033	0.957704350123583	0.999999178804216	0.811221604380105	1493	1
WP183	Proteasome degradation	3/643	59/6033	0.958753802630486	0.999999178804216	0.811221604380105	3134/3458/5698	3
WP5072	Modulators of TCR signaling and T cell activation	3/643	59/6033	0.958753802630486	0.999999178804216	0.811221604380105	3937/1326/8651	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	3/643	60/6033	0.962089627067654	0.999999178804216	0.811221604380105	775/1496/3678	3
WP1601	Fluoropyrimidine activity	1/643	29/6033	0.962233259843905	0.999999178804216	0.811221604380105	1890	1
WP722	Serotonin HTR1 group and FOS pathway	1/643	29/6033	0.962233259843905	0.999999178804216	0.811221604380105	3352	1
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2/643	46/6033	0.964126129704562	0.999999178804216	0.811221604380105	8503/11040	2
WP2034	Leptin signaling pathway	4/643	75/6033	0.965785724285948	0.999999178804216	0.811221604380105	3553/3557/9021/6772	4
WP2363	Gastric cancer network 2	1/643	30/6033	0.966277899071148	0.999999178804216	0.811221604380105	51316	1
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1/643	30/6033	0.966277899071148	0.999999178804216	0.811221604380105	8503	1
WP3888	VEGFA-VEGFR2 signaling pathway	33/643	409/6033	0.970804210406657	0.999999178804216	0.811221604380105	56999/301/6347/1003/79094/1558/22943/1847/1960/2022/24147/6624/1839/3383/6300/4319/4313/4688/4855/4929/8013/5228/5328/5329/5743/27289/57758/6401/9047/6648/6772/8794/81567	33
WP5224	2q37 copy number variation syndrome	6/643	104/6033	0.972131705204632	0.999999178804216	0.811221604380105	1293/6373/27128/3553/7124/54657	6
WP3998	Prader-Willi and Angelman syndrome	1/643	32/6033	0.973115693614246	0.999999178804216	0.811221604380105	2562	1
WP244	Alpha 6 beta 4 signaling pathway	1/643	33/6033	0.975996315011686	0.999999178804216	0.811221604380105	3918	1
WP3981	miRNA regulation of prostate cancer signaling pathways	1/643	33/6033	0.975996315011686	0.999999178804216	0.811221604380105	5159	1
WP422	MAPK cascade	1/643	33/6033	0.975996315011686	0.999999178804216	0.811221604380105	6300	1
WP185	Integrin-mediated cell adhesion	5/643	94/6033	0.977703455083329	0.999999178804216	0.811221604380105	11131/3678/3687/3689/6300	5
WP3286	Copper homeostasis	2/643	51/6033	0.977788763069112	0.999999178804216	0.811221604380105	79689/54739	2
WP313	Hepatocyte growth factor receptor signaling	1/643	34/6033	0.978568709919601	0.999999178804216	0.811221604380105	3082	1
WP4659	Gastrin signaling pathway	6/643	108/6033	0.978999343194334	0.999999178804216	0.811221604380105	330/9076/4316/8503/5743/5054	6
WP2795	Cardiac hypertrophic response	2/643	53/6033	0.981704836058276	0.999999178804216	0.811221604380105	5320/7124	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/643	53/6033	0.981704836058276	0.999999178804216	0.811221604380105	3082/8503	2
WP4223	Ras signaling	10/643	161/6033	0.98239109459413	0.999999178804216	0.811221604380105	2786/22808/5159/8503/51365/84647/5320/50487/283748/115727	10
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3/643	70/6033	0.984044112549725	0.999999178804216	0.811221604380105	5743/7042/7043	3
WP35	G protein signaling pathways	4/643	85/6033	0.984645945429077	0.999999178804216	0.811221604380105	2769/2786/3760/5142	4
WP524	G13 signaling pathway	1/643	37/6033	0.984748682831098	0.999999178804216	0.811221604380105	398	1
WP51	Regulation of actin cytoskeleton	7/643	127/6033	0.986254688509733	0.999999178804216	0.811221604380105	2255/2252/2254/22808/5159/5288/8503	7
WP3584	MECP2 and associated Rett syndrome	2/643	56/6033	0.986352262187135	0.999999178804216	0.811221604380105	2893/6890	2
WP4263	Pancreatic adenocarcinoma pathway	4/643	87/6033	0.986977399716136	0.999999178804216	0.811221604380105	8503/6772/7042/7043	4
WP366	TGF-beta signaling pathway	7/643	130/6033	0.988882586556399	0.999999178804216	0.811221604380105	467/1278/50943/3726/4312/4321/3371	7
WP2853	Endoderm differentiation	6/643	118/6033	0.989903486674742	0.999999178804216	0.811221604380105	22943/1846/1847/3227/6772/30009	6
WP4155	Endometrial cancer	2/643	61/6033	0.991668868474806	0.999999178804216	0.811221604380105	1496/8503	2
WP4971	Phosphoinositides metabolism	1/643	44/6033	0.993109133440339	0.999999178804216	0.811221604380105	5288	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	2/643	64/6033	0.993821546852628	0.999999178804216	0.811221604380105	6772/7253	2
WP4540	Hippo signaling regulation pathways	3/643	84/6033	0.995505813719867	0.999999178804216	0.811221604380105	1001/1003/5159	3
WP107	Translation factors	1/643	49/6033	0.996095550760132	0.999999178804216	0.811221604380105	728689	1
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	6/643	134/6033	0.997068258816447	0.999999178804216	0.811221604380105	249/1959/2562/4688/6696/6772	6
WP2857	Mesodermal commitment pathway	5/643	122/6033	0.997616192173786	0.999999178804216	0.811221604380105	8553/22943/2296/3624/6615	5
WP481	Insulin signaling	7/643	156/6033	0.998416105417465	0.999999178804216	0.811221604380105	1326/5600/6300/5288/8503/8651/9021	7
WP3680	Physico-chemical features and toxicity-associated pathways	1/643	58/6033	0.99859743222201	0.999999178804216	0.811221604380105	11211	1
WP4022	Pyrimidine metabolism	2/643	79/6033	0.998649638703536	0.999999178804216	0.811221604380105	956/1890	2
WP2261	Glioblastoma signaling pathways	2/643	82/6033	0.999008189514133	0.999999178804216	0.811221604380105	5159/5288	2
WP673	ErbB signaling pathway	2/643	83/6033	0.999105398991871	0.999999178804216	0.811221604380105	1839/8503	2
WP45	G1 to S cell cycle control	1/643	62/6033	0.999110634725664	0.999999178804216	0.811221604380105	84699	1
WP4685	Melanoma	1/643	63/6033	0.99920640794144	0.999999178804216	0.811221604380105	8503	1
WP437	EGF/EGFR signaling pathway	6/643	157/6033	0.999557753053419	0.999999178804216	0.811221604380105	9046/7837/9047/6456/6772/7291	6
WP4656	Joubert syndrome	1/643	71/6033	0.999681273513625	0.999999178804216	0.811221604380105	6469	1
WP179	Cell cycle	3/643	115/6033	0.999768614846835	0.999999178804216	0.811221604380105	994/7042/7043	3
WP23	B cell receptor signaling pathway	2/643	96/6033	0.99976875249686	0.999999178804216	0.811221604380105	27071/4067	2
WP138	Androgen receptor signaling pathway	1/643	85/6033	0.999935620471062	0.999999178804216	0.811221604380105	8431	1
WP2446	Retinoblastoma gene in cancer	1/643	86/6033	0.999942580127603	0.999999178804216	0.811221604380105	994	1
WP4549	Fragile X syndrome	1/643	101/6033	0.999989702905496	0.999999178804216	0.811221604380105	4318	1
WP4803	Ciliopathies	2/643	139/6033	0.999997662879452	0.999999178804216	0.811221604380105	122481/10309	2
WP4352	Ciliary landscape	5/643	201/6033	0.999998236154525	0.999999178804216	0.811221604380105	875/30845/3934/2040/339488	5
WP411	mRNA processing	1/643	123/6033	0.999999178804216	0.999999178804216	0.811221604380105	10772	1
